|
pubmed:abstractText |
Favorable clinical outcomes have been observed with glucose-insulin-potassium infusion (GIK) in acute myocardial infarction (MI). The mechanisms of this beneficial effect have not been delineated clearly. GIK has metabolic, anti-inflammatory and profibrinolytic effects and it may preserve the ischemic myocardium. We sought to assess the effect of GIK infusion on infarct size and left ventricular function, as part of a randomized controlled trial.
|
|
pubmed:affiliation |
Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. i.c.c.van.der.horst@thorax.umcg.nl
|
